Cleared Traditional

K161061 - IMPAX Volume Viewing 4.0

K161061 is an FDA 510(k) clearance for IMPAX Volume Viewing 4.0, manufactured by Agfa Healthcare N.V.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 68-day FDA review.

K161061 · Agfa Healthcare N.V. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2016
Decision
68d
Days
Class 2
Risk

K161061 is an FDA 510(k) clearance for the IMPAX Volume Viewing 4.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Agfa Healthcare N.V. (Mortsel, BE). The FDA issued a Cleared decision on June 22, 2016 after a review of 68 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Agfa Healthcare N.V. devices

FDA 510(k) Submission Details - K161061

510(k) Number K161061 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 15, 2016
Decision Date June 22, 2016
Days to Decision 68 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 107d · This submission: 68d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Agfa Healthcare Corporation
ShaeAnn Cavanagh

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1151
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K161061.
SIMPLANT Online Case Review and SIMPLANT Editor
K161118 · Dentsply Sirona · Jul 2016
Multi Modality Viewer
K161419 · Vital Images, Inc. · Jul 2016
syngo®.via protoNeo (Version VA10A)
K161685 · Siemens Healthcare GmbH · Jul 2016
Ez3D-i / E3
K161246 · Ewoosoft Co., Ltd. · May 2016
EzDent-i / E2 / Prora View
K161117 · Ewoosoft Co., Ltd. · May 2016
DICOM Viewer
K153653 · Brainlab AG · Apr 2016